Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Oral Contraceptive Pills Compared to Vaginal Rings

This study has been completed.
Information provided by:
University of California, San Francisco Identifier:
First received: July 25, 2006
Last updated: April 19, 2007
Last verified: March 2006

The purpose of this study is to determine whether teens and young women would prefer the Nuvaring to oral contraceptive pills after having tried both methods.

Condition Intervention
Drug: OCPs
Device: vaginal ring

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • Satisfaction

Secondary Outcome Measures:
  • Compliance
  • Acceptability

Estimated Enrollment: 130
Study Start Date: April 2003
Estimated Study Completion Date: August 2004
Detailed Description:

Sexually active young women (n=130), aged 15-21 years, were randomly assigned to use either the vaginal ring or oral contraceptive pills for an initial study interval of three 28-day cycles, followed by three cycles of the alternate method. Participants completed surveys about method use, acceptability and side effects at baseline, after three cycles, and after six cycles, as well as in a follow up telephone interview one month after study completion.


Ages Eligible for Study:   15 Years to 21 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Sexually active young women (n=130), English or Spanish speaking, aged 15-21 years, able and willing to try oral contraceptives and vaginal rings for 6 months

Exclusion Criteria:

  • Not able or willing to use hormonal contraceptives, moving out of the area, pregnant or intending to become pregnant during the study time frame, not sexually active
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00357526

United States, California
New Generation Health Center
San Francisco, California, United States, 94110
Sponsors and Collaborators
University of California, San Francisco
Principal Investigator: Felicia Stewart, MD University of California, San Francisco
  More Information

No publications provided Identifier: NCT00357526     History of Changes
Other Study ID Numbers: H10857-19674-04
Study First Received: July 25, 2006
Last Updated: April 19, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, San Francisco:
vaginal ring
Oral contraceptive pills
Young women
Patient satisfaction

Additional relevant MeSH terms:
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Contraceptive Agents, Female
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses processed this record on March 03, 2015